At the University of Findlay, pharmacy students are developing an oral compound that targets glioblastomas, the most aggressive form of cancer occurring in the brain.
Using chemistry, physiology and pharmacology, they are researching an efficient way to direct medication to the brain. If successful, this kind of medication could remove the need for risky medical procedures which require physical access to the brain tissue. The research is in its infancy; years worth of study remain to determine the drug’s efficacy.
For more, check out this press release.